Lancôme has appointed Dr. Macrene Renee Alexiades-Armenakas as its consulting dermatologist and skin care authority, working closely with the brand on skin care innovation and sharing her insights on cutting-edge research projects.
"Dr. Macrene is renowned throughout the industry as an incredible resource with an exceptional background," said Xavier Vey, president, Lancôme USA. "Her devoted patient following, prestigious publication record, and years of sterling professional experience truly make her best-in-class. As the brand's consulting dermatologist, Dr. Macrene will lend her professional expertise to Lancôme Skincare. Our passion and knowledge in anti-aging treatment have pioneered technologies and innovative formulas to achieve youthful, radiant skin. We are excited to enter into this partnership and are honored to have Dr. Macrene serving as our skin care ambassador and resident dermatological expert."
With more than 20 years of experience in scientific research and clinical dermatology, Dr. Macrene represents the top of her field and was the natural choice as a brand voice for Lancôme.
"I've spent years in the laboratory investigating plant molecular biology, cell and developmental biology and genetics," explains Dr. Macrene. "So I have a keen understanding of how the latest cosmetic compounds affect skin and the aging process. I'm thrilled to have the opportunity to align with Lancôme on its groundbreaking work in this field."
As director of her own research clinic and private practice in laser and aesthetic dermatology in New York City, Dr. Macrene continuously examines the latest scientific literature to critically evaluate new molecules for their efficacy and safety. In her new role as Lancôme's consulting dermatologist, she'll lend her valuable insight to a Lancôme peer reviewed study. For the past 15 years, Dr. Macrene has conducted clinical trials in dermatology and laser surgery and maintains a prestigious dermatology practice; this scientific and clinical background allows her to bridge the science behind new technologies to their clinical results on real people.